#cvCAD
Stress CMR-guided #cvImaging in patients w/ chest pain & nonobstructive #cvCAD was superior to angiography only in correctly diagnosing microvascular angina & improving chest pain symptoms & QoL, based on findings from CorCMR trial presented at #AHA25. 🔗 https://bit.ly/4hRZ0dJ
November 10, 2025 at 3:30 PM
Four key plasma proteins associated w/ potential causal roles in blood pressure regulation and increased risk of cardiovascular events, including #cvCAD and stroke, were identified in a Mendelian randomization study.

Read the journal scan for more ➡️ https://bit.ly/435QUZ3
Key Plasma Proteins Linked to Causal Roles in BP Regulation and Risk of CV Events - American College of Cardiology
bit.ly
October 29, 2025 at 8:00 PM
In patients with de novo coronary artery disease, #DCB angioplasty with rescue stenting was associated with a higher rate of Device-oriented Composite Endpoint compared to intended DES implantation regarding DoCE at 3 years. https://bit.ly/4nePRNp

#TCT2025 #JACC #cvCAD #CardioSky
October 27, 2025 at 10:00 PM
FFR-guided #PCI using zotarolimus DES provides significantly better long-term value than CABG for treatment of patients with multivessel CAD, with equivalent clinical outcomes at substantially lower cost. https://bit.ly/47vJgJS

#TCT2025 #JACC #cvCABG #cvCAD #CardioSky
October 25, 2025 at 3:20 PM
🏆 Congratulations to the #ACCMidEast abstract competition winners! Their research explores:
📊 Non-HDL-C levels in Middle Eastern #ASCVD patients
🫀 LVMI impact on RV impairment
🔬Comparative efficacy of imaging agents in detecting #cvCAD

🔗 https://bit.ly/3WnSt0v

#ACCIntl
October 8, 2025 at 3:19 PM
Noninferiority was not demonstrated in the OPTION-STEMI trial comparing immediate complete revascularization with staged complete revascularization in patients with #STEMI and multivessel CAD. Read more: https://bit.ly/47QKKyX

#ESCCongress #cvCAD
August 31, 2025 at 3:55 PM
As compared with SPECT myocardial perfusion imaging, vasodilator stress #CMR has superior specificity and accuracy for detection of obstructive #cvCAD. Sensitivity of the two modalities is not significantly different. #medblue #meded
November 11, 2023 at 8:31 PM